Introduction:
Idiosyncratic adverse drug reactions (IADRs) occur in a minority of patients during drug therapy. They pose a unique public health problem because they cause severe illness and also often result in the withdrawal of otherwise useful drugs from the market. There are currently no predictive preclinical tests to identify drugs that have idiosyncratic potential, and the mechanisms of IADRs are poorly understood. Animal models that share the same sensitivity factors as humans and reproduce the liver lesions seen in people would be useful to study mechanisms of pathogenesis of IADRs and to develop strategies for therapy and prevention. The first step toward this effort must occur with drugs that are known to cause IADRs in people.
Halothane is an inhaled anesthetic that produces a mild and reversible liver injury in 1 in 5 patients (Trowell et al., 1975) . A more severe IADR, or "halothane hepatitis," is observed in 1 in 6,000-22,000 patients who receive the drug (Mushin et al., 1971) .
Although increasing numbers of reports of halothane-associated liver failure curtailed the use of halothane in the United States, it is still used in other countries, and cases of liver failure from halothane continue to be reported (Eghtesadi-Araghi et al., 2008) .The most prominent histologic feature seen in liver biopsies from patients who had halothane hepatitis is centrilobular necrosis (Blackburn et al., 1964) . Other findings include fatty degeneration, vacuolation, and inflammatory infiltrate. Risk factors for severe halothane hepatotoxicity are female sex, genetics, age, and multiple halothane exposures (Inman and Mushin, 1974; Cousins et al., 1985) . Other susceptibility factors, This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on February 2, 2010 as DOI: 10.1124/jpet.109.164541 at ASPET Journals on July 8, 2017
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Halothane is metabolized by cytochrome P450 2E1 in hepatocytes to form trifluoroacetyl-(TFA-) chloride, which binds covalently to proteins and lipids making TFAadducts. Direct toxicity from TFA adducts is thought to cause the mild form of injury (Bourdi et al., 2001) . The severe form of halothane hepatotoxicity is widely thought to result from an adaptive immune response to TFA-adducted or halothane-modified macromolecules. This is supported by the finding that repeated exposure is a risk factor and by the appearance of antibodies and immune complexes in the sera of some halothane-treated patients (Bird and Williams, 1989) .
Despite its popularity, there exists clinical evidence that is incongruent with a strictly adaptive immune-mediated hypothesis. For example, a recent retrospective study demonstrated that 39% of halothane hepatitis patients had no previous history of halothane exposure (Eghtesadi-Araghi et al., 2008) . Additionally, some people with antibodies in their serum did not develop liver injury (Walton et al., 1976b; Njoku et al., 2002) . Attempts at developing animal models of liver damage using a halothane sensitization and challenge paradigm have resulted in a humoral immune response without associated liver pathology (Hastings et al., 1995) 
. Pohl and Gillette noted in
This article has not been copyedited and formatted. The final version may differ from this version.
jpet.aspetjournals.org
Downloaded from
1982 that after years of intensive investigation the adaptive immunity theory for halothane hepatitis was unproven (Pohl and Gillette, 1982) . This remains true today.
It seems possible that halothane hepatitis occurs from a confluence of susceptibility factors, such as proposed by the "multiple determinant hypothesis," in which an individual's chance of developing an IADR is a product of several discreet probabilities of specific risk factors particular to the individual and the drug (Li, 2002) . This product would be expected to be small, which would explain the rare frequency of IADRs. If the major risk factors could be incorporated into an animal model, it follows that liver injury would occur with high frequency. Animal models of halothane hepatotoxicity have been developed, but most reproduce the mild type of injury (Lind et al., 1990; Bourdi et al., 2001; You et al., 2006) . Attempts to develop animal models of severe, halothane-induced hepatotoxicity have focused on using repeated exposures (Hastings et al., 1995) , drug metabolizing enzyme inducers, glutathione depletion techniques, and/or hypoxic conditions (McLain et al., 1979; Lind et al., 1992) . However, low incidence of responders and/or lack of severe hepatotoxicity limit the usefulness of these models. High incidence of severe halothane-induced liver injury (n=4) was reported in studies using female strain 2 guinea pigs (Lind et al., 1987) , but few studies have followed the original report. Here we report a mouse model developed using risk factors seen in humans. The result is the first animal model of halothane hepatitis in which severe liver injury occurs reproducibly without extensive chemical manipulations and which demonstrates histopathologic findings consistent with those observed in humans. The results raise the possibility that human risk factors might be useful in developing models of hepatotoxic IADRs and suggest that inflammation is a critical factor in the pathogenesis of halothane hepatitis.
Methods:
Materials: Halothane (2-bromo-2-chloro-1,1,1-trifluoro-ethane), highly refined, low acidity olive oil, sodium citrate, oil red O, and lipopolysaccharide (LPS) were purchased from Sigma-Aldrich (St. Louis, MO).
Isoflurane (2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane) was purchased from Abbott Laboratories (Chicago, IL). LPS from Escherichia coli O55:B5 (Lot 075K4038) with an activity of 3.3 x 10 6 endotoxin units (EU/mg) was used in these studies. Rabbit anti-CD18 antiserum against amino acids 89-100 was purchased from New England Peptide (Gardnew, MA).
Alanine aminotransferase (ALT) reagent was purchased from Thermo Electron Corp.
(Louisville, CO). Anti-TFA-adduct rabbit serum was generously donated by Dr. Lance
Pohl. Fluorescein isothiocyanate (FITC) goat anti-rabbit immunoglobulin G (IgG) and horse radish peroxidase (HRP) goat anti-rabbit IgG secondary antibodies were purchased from Invitrogen (Eugene, OR) and Santa Cruz (Santa Cruz, CA), respectively. RIPA buffer and HALT protease inhibitor were purchased from Thermo Scientific (Santa Cruz, MA).
Animals: C57BL/6 or BALB/cJ mice were purchased from Jackson Laboratory (Bar Harbor, ME) and used at an age of 4,8, or 10-12 weeks, with weights ranging from 10g to 27g. They were housed under conditions of controlled temperature and humidity and 12hr light/dark cycle. They were given continuous access to bottled spring water according to a previously described method (Lillie and Ashburn, 1943) .
Immunohistochemistry and Microscopy:
For PMN identification, formalinfixed liver sections were probed with anti-mouse PMN antibodies using the protocol described by Yee et al. (2003) . Genetic Background as a Sensitivity Factor for Halothane-induced Liver Injury.
Responses to halothane were compared in two inbred mouse strains, BALB/cJ and C57BL/6. As demonstrated in Figure 2 , halothane caused dose-dependent hepatotoxicity in the BALB/cJ mice. In contrast, there were no significant increases in plasma ALT activity at any halothane dose up to 30mmol/kg in the C57BL/6 mice ( Figure 3A ). The extent of TFA-adduct formation in liver homogenates from halothanetreated C57BL/6 and BALB/cJ female mice was similar ( Figure 3B ).
Insensitivity to Isoflurane-induced Liver Injury. Isoflurane (1-chloro-2,2,2-trifluoroethyl difluoromethyl ether) is an inhaled anesthetic that is structurally similar to halothane but has less propensity than halothane to cause hepatotoxic IADRs in humans (Hussey et al., 1988) . In female BALB/cJ mice, halothane exposure caused dose-dependent hepatotoxicity, whereas ALT activity was not increased at doses of isoflurane up to 30mmol/kg (Figure 4 ).
Age as a Sensitivy Factor for Halothane-Induced Liver Injury in BALB/cJ Mice.
Responses to halothane were compared in 4-and 8-week old, male and female BALB/cJ mice. After 15mmol/kg halothane exposure, plasma ALT activity was <2,000U/L in 8-week old males and 4-week old mice of either sex ( Figure 5 ). Eightweek old female mice had plasma ALT activity of ~8,000U/L.
This article has not been copyedited and formatted. The final version may differ from this version. (<30min), mild coordination loss following administration of 15mmol/kg halothane. In male mice, halothane treatment caused an increase in plasma ALT activity at 12 and 24hrs after administration, at which times the ALT activity was 124 and 600U/L, respectively ( Figure 6 ). The injury in female mice followed a similar time course but was much more severe, reaching an ALT activity of nearly 7000U/L at these times.
There were no significant lesions in untreated female, mice, whereas halothanetreated females developed pronounced centrilobular necrosis within 12hrs (Figure 7 ).
Immunohistochemical staining for PMNs revealed a greater number in livers of halothane-treated mice compared to control mice. Livers from halothane-treated mice also had greater Oil Red O staining at 6hrs compared to livers from untreated mice at the same time (Figure 7 ), indicating that halothane administration caused steatosis.
Halothane Bioactivation in Male and Female BALB/cJ Mice. A positive correlation has been reported between the severity of liver injury and the formation of TFA-adducts in livers of halothane-treated guinea pigs (Bourdi et al., 2001) . As shown in Figure 8A , TFA-adducted proteins in the livers from halothane-treated male mice had a PMNs and attenuated the increase in plasma ALT activity (You et al., 2006) . CD18 is an integrin on leukocyte plasma membranes and is needed for adhesion to vascular endothelium and transmigration of PMNs into the liver parenchyma. Mice given CD18 antiserum in our model of severe halothane hepatitis had less hepatocellular injury compared to those treated with control serum or saline (Figure 11 ). 
Enhanced Sensitivity of Male

Discussion:
Few animal models reproduce severe liver injury caused by drugs with human idiosyncratic potential. Most of the models have involved administration of an inflammagen that prompts the appearance of liver injury from drugs that cause hepatotoxic IADRs in humans (Deng et al., 2009) . In other attempts at developing animal models, liver injury has been either modest (You et al., 2006) 
or nonexistent
This article has not been copyedited and formatted. The final version may differ from this version. (Ong et al., 2007) . For example, nevirapine produces idiosyncratic dermal and liver toxicity in humans; a rat model reproduced the skin lesions but failed to reproduce the liver toxicity (Shenton et al., 2003) . Accordingly, it is noteworthy that the present model in mice based on human risk factors resulted in severe liver injury without the coadministration of other agents.
Although an adaptive immune response is commonly thought to be the mode of action of halothane hepatitis, not all human cases support a strictly adaptive-immune mechanism. For example, 4 out of 5 lymphocyte transformation tests and a leukocyte migration inhibition test failed to demonstrate evidence of cellular hypersensitivity for halothane hepatitis patients (Walton et al., 1976a) . Antibodies to halothane-modified proteins form in humans (Bird and Williams, 1989) ; however, evidence linking antibodies to the pathogenesis of hepatitis is lacking (Pohl et al., 1988) . Several retrospective clinical studies indicate that halothane hepatitis can occur on the first exposure to halothane (Walton et al., 1976b; Weber et al., 1994) , with the the most recent study reporting that 39% of affected patients had no previous exposure (Eghtesadi-Araghi et al., 2008) . Furthermore, multiple exposures was only a risk factor for halothane hepatitis when exposures occurred within 28 days (Inman and Mushin, 1974; Inman and Mushin, 1978) . This timeframe supports a paradigm in which the first exposure renders the liver more sensitive to a second exposure; however, an adaptive immune response is not the only explanation for the results. repeated exposure at intervals that overwhelm the regenerative capacity of the liver could produce cumulative damage. Moreover, the observations that patients who developed clinical signs of liver failure upon first exposure to halothane but not upon subsequent exposure cast doubt on a strictly adaptive immune-mediated mode that explains all instances of idiosyncratic halothane hepatitis (Walton et al., 1976b) .
Data presented in Figure 1 demonstrate severe hepatotoxicity resulting from a single exposure of mice to halothane. All of halothane-treated mice developed liver injury at the largest dose administered. The lack of requirement for a priming exposure followed by reexposure indicates a mode of action other than adaptive immunemediated pathogenesis in this model. Importantly, the histopathological findings in livers from halothane-treated, female mice were consistent with the changes in postmortem specimens from patients who died from halothane-induced liver failure (Blackburn et al., 1964; Kumar et al., 2005) . Centrilobular necrosis, inflammatory cell infiltrate and steatosis, all hallmarks of human halothane hepatitis, were observed in livers of halothane-treated mice. Thus, this mouse model mimics to a substantial degree the histopathological features associated with idiosyncratic halothane hepatitis in human patients.
The present study extends the work of Ju and coworkers (You et al., 2006) by imposing several human risk factors to enable the expression of severe halothane hepatotoxicity. The magnitude of the response to halothane observed in this mouse model was much greater than the mild hepatotoxicity reported in a similar murine model. For example, the 6000-10,000U/L plasma ALT activity reported here for female, BALB/cJ given 30mmol/kg halothane is much greater than the 1200U/L reported earlier.
The rarity and heterogeneous clinical presentation of many IADRs and the unknown mechanisms of pathogenesis are barriers to the development of adequate animal models. We considered the influence of several risk factors known to be important in people when developing an animal model of severe halothane hepatotoxicity in mice. Female sex is a risk factor for halothane hepatotoxicity with a 2:1 preponderance in women (Cousins et al., 1985) . It was recently reported that females
were the most at-risk group, representing 81.4% of patients who developed halothane hepatitis (Eghtesadi-Araghi et al., 2008) . Female mice developed severe hepatitis at doses of halothane that produced only a mild response in male mice (Figure 1 ). The disparity in toxicity between males and females was not due to differences in bioactivation of halothane (Figure 8 ). The greater sensitivity of females has been reported previously for mice and guinea pigs (Lind et al., 1987; You et al., 2006) .
Children are thought to be less susceptible to halothane hepatotoxicity, with an estimated incidence of 1-80,000 to -200,000 (Carney and Van Dyke, 1972; Warner et al., 1984) . Four-week old female mice had a milder response to halothane than 8-week The occurrence of rare, halothane hepatitis among closely related family members and an increased frequency of the HLA-DR2 haplotype in patients with severe halothane hepatitis suggest a genetic predisposition (Hoft et al., 1981; Otsuka et al., 1985) . The findings that guinea pigs sensitive to halothane produce offspring that are also sensitive to halothane (Lunam et al., 1986) and that there are strain-dependent variations in halothane metabolism in rats (Gourlay et al., 1981) suggest genetic determinants of halothane sensitivity in animals as well. C57BL/6 mice were insensitive to severe halothane hepatitis at all doses tested ( Figure 4A ), consistent with reports in which sensitivity to more modest liver injury was strain-dependent (Lind et al., 1987; You et al., 2006) . The difference in sensitivity between C57BL/6 and BALB/cJ mice was not due to a difference in halothane bioactivation ( Figure 4B ). We are not aware of specific genetic differences between BALBc/J and C57BL/6 that may account for the difference in sensitivity; however, the results indicate that, as in humans, genetic differences are important in the hepatotoxic response to halothane in animals. Whether the genetic determinants that render BALB/cJ mice sensitive are the same as in susceptible humans is unknown.
Fasting has not been studied as a risk factor for human halothane hepatitis, yet patients are uniformly fasted prior to general anesthesia. Fasting mice before exposure to halothane increased their sensitivity to liver injury (Figure 2 ). Accordingly, consideration should be given to fasting as a potential contributor to risk for halothane hepatitis in humans. Fasting increases hepatic CYP2E1 expression and decreases hepatic glutathione stores in mice (Walker et al., 1982) , and this may reduce protection against reactive metabolites generated during oxidative metabolism of halothane.
Treatment of guinea pigs with an inhibitor of glutathione biosynthesis increased covalent binding of reactive halothane intermediates and enhanced liver injury (Lind et al., 1992) .
Halothane treatment resulted in elevated plasma TNFα concentration in female, but not male, mice (Figure 9 ). Moreover, in the halothane-treated, female mice hepatic PMN accumulation occurred to a greater extent than in males (Figure 10 ), and liver damage was attenuated by neutralization of CD18, an adhesion molecule required for transmigration of PMNs into the hepatic parenchyma. These results support the hypothesis that PMNs contribute to the pathogenesis of severe halothane hepatitis in mice. The findings also point to a sexually dimorphic inflammatory response to halothane, inasmuch as male mice responded to halothane with only modest liver injury, minimal hepatic accumulation of PMNs, and no increase in serum TNFα. Sexually dimorphic inflammatory responses have been reported in both humans and experimental animals (Wichmann et al., 1996; Marriott and Huet-Hudson, 2006) . For example, female sex is a risk factor in alcohol-induced liver injury in people (Becker et al., 1997) as well as animals (Nanji et al., 2001) , and alcohol consumption produces greater concentration of inflammatory mediators in female compared to male rats.
Interestingly, although male, BALB/cJ mice responded to halothane with only modest liver injury and inflammation, cotreatment with a nontoxic dose of LPS led to pronounced hepatotoxicity. Similar results have been observed by others in a hypoxiahalothane model in rats (Lind et al., 1984) .
LPS effects biological responses through
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Toll-like receptor 4. A viral mimetic (PoIyI:C) that stimulates Toll-like receptor 3 potentiated halothane hepatotoxicity in female mice (Cheng et al., 2009) . These results suggest that inflammation might contribute to halothane hepatotoxicity and that the contribution of inflammatory stimuli might be mediated through at least Toll-like receptors 3 or 4. It is tempting to speculate that the modest hepatotoxic response to halothane alone in male mice is tantamount to the mild liver injury seen in 20% of patients, whereas the pronounced response seen in combination with LPS relates to the rarer, severe halothane hepatitis seen in humans.
In summary, to our knowledge this is the first animal model of idiosyncratic hepatotoxicity based on human risk factors for an IADR. The animal model of severe halothane hepatitis shares the human risk factors of female sex, mature age, and genetic predisposition and a possible contribution of fasting, which is imposed on all individuals prior to general anesthesia. The model in female, BALB/cJ mice captured important aspects of the pathology of human halothane hepatitis, including severe centrilobular necrosis, inflammatory infiltrate and steatosis. Importantly, the results suggest that an adaptive immune response requiring sensitization and challenge exposures to halothane is not needed to precipitate severe halothane hepatitis, since injury was produced in mice upon a single exposure to the drug. The greater sensitivity of female mice was associated with a more robust inflammatory response than occurred in males, and the importance of inflammatory stress in the hepatotoxicity was suggested by the ameliorative effect of CD18 neutralization. The ability of a nontoxic dose of LPS to convert a modestly hepatotoxic response in males to a robust, female-like response Blood was collected at various times for the determination of plasma ALT activity. There was no time-or sex-related difference in ALT activity in the vehicle-treated mice, so the results were combined and represented as zero-time. *significantly different from male mice at the same time. #significantly different from vehicle-treated animals (zero-time). Immunohistochemical staining for PMNs in a cotreated mouse; PMNs stain bright pink
